:: Home   :: Contact ICare   :: Site Map          
 | Home | About ICare | Research | CTR Library | Register | Contact ICare
Ovarian Cancer News
Ovarian Cancer Breakthrough News
 

Feb 10, 2009
SGO: Invasive Endometrial Cancer Common in Atypical Hyperplasia

  By Charles Bankhead, Staff Writer, MedPage Today

SAN ANTONIO, Feb. 10 -- Complex atypical endometrial hyperplasia may confer a greater risk of deeply invasive cancer than previously recognized, according to a study reported here.    <READ MORE>

 

Feb 9, 2009
SGO: Rectovaginal Nodules Predict Bowel Perforation Risk with Bevacizumab

  By Charles Bankhead, Staff Writer, MedPage Today

SAN ANTONIO, Feb. 9 -- Rectovaginal nodularity more than triples the risk of bowel perforation during bevacizumab (Avastin) therapy for advanced ovarian cancer, a retrospective chart review suggested.    <READ MORE>

 

Feb 10, 2009
SGO: Novel Drug Combination Shows Promise in Advanced Ovarian Cancer

  By Charles Bankhead, Staff Writer, MedPage Today

SAN ANTONIO, Feb. 10 -- Patients with advanced ovarian cancer had a 70% one-year progression-free survival with a novel platinum-taxane doublet plus bevacizumab (Avastin) as first-line systemic therapy, according to preliminary data from a phase II trial.    <READ MORE>

 

June 23, 2008
Ovarian Cancer Symptoms Plus Blood Test Aid Early Detection

  By Crystal Phend, Staff Writer, MedPage Today

SEATTLE, June 23 -- Four simple questions about ovarian-cancer related symptoms may boost early detection when coupled with results of a blood test, researchers found.    <READ MORE>

 

Mar 13, 2008
SGO: Statin Use Linked to Survival Benefit in Ovarian Cancer

  By Charles Bankhead, Staff Writer, MedPage Today

TAMPA, Fla., March 13 -- If ovarian cancer patients were taking statins at the time of surgical debulking, they had a significantly better progression-free and overall survival than other patients, according to a retrospective study.    <READ MORE>

 

Mar 12, 2008
SGO: Extended Chemotherapy May Reduce Recurrence in Ovarian Cancer

  By Charles Bankhead, Staff Writer, MedPage Today

TAMPA, Fla., March 12 -- In high-risk, early-stage ovarian cancer, six cycles of adjuvant chemotherapy significantly improved recurrence-free survival (P=0.007), but only for patients with serous tumors, an exploratory analysis of data from a multicenter trial showed.    <READ MORE>

 

Feb 13, 2008
Six-Marker Panel Highly Accurate in Detecting Ovarian Cancer

  By Michael Smith, North American Correspondent, MedPage Today

SNEW HAVEN, Conn., Feb. 13 -- Even for early ovarian cancer, a panel of six biomarkers can detect the disease with high accuracy, according to results of a case-control analysis here.   <READ MORE>

 

Jan 21, 2008
High-Quality Preop Ultrasound Improves Evaluation of Adnexal Masses

  By Charles Bankhead, Staff Writer, MedPage Today

SAN DIEGO, March 5 -- A highly sensitive blood test for ovarian cancer, based on six biomarkers, could be used to detect the disease while it is still in its curable early stages, researchers said here.  <READ MORE>

 

March 5, 2007
SGO: Ovarian Cancer Screening Test Found Highly Accurate

  LONDON, Jan. 21 -- For suspected ovarian cancer, high-quality ultrasonography can double the sensitivity of accurate diagnoses, help reduce major staging procedures, and shorten hospital stays, investigators here concluded.  <READ MORE>
   

 

:: 12 Element Approach ::
Explore and supplement your therapy with ICare's unique 12-Element approach to Patient Survival.

:: Breakthrough Newsletter ::
Breaking news on research for gentler, more effective therapies and information on lifesaving treatment options.

:: ICare Bulletin Board ::
View pertinent information regarding meetings and events pertaining to cancer patients. This is also a resource for contacting other patients about information and treatment options.

 
Copyright ⓒ ICare.  All rights reserved.